Flows and flaws in primary central nervous system lymphoma.
Ferreri
Andrés J M
AJ
Illerhaus
Gerald
G
Zucca
Emanuele
E
Cavalli
Franco
F
D000465:Algorithms; D000964:Antimetabolites, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000627:therapeutic use; D016543:Central Nervous System Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D003561:Cytarabine / Q000627:therapeutic use; D003657:Decision Making; D004359:Drug Therapy, Combination; D006801:Humans; D008228:Lymphoma, Non-Hodgkin / Q000175:diagnosis / Q000188:drug therapy / Q000473:pathology*; D008727:Methotrexate / Q000627:therapeutic use; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D000970:Antineoplastic Agents; D003561:Cytarabine; D008727:Methotrexate